Laborie is set to exit the medical device manufacturer after another of its investors, Olympus, announced its intention to pay $260m for its remaining shares.

Camera and optics technology producer Olympus has agreed to acquire one of its portfolio companies, Israel-based medical device maker Medi-Tate for $260m. Olympus invested an undisclosed amount in Medi-Tate in 2018 as part of a distribution agreement, and held an 18.5% stake prior to the transaction, which involves it exercising a call option to buy…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.